Compare · CRWD vs SNCE
CRWD vs SNCE
Side-by-side comparison of CrowdStrike Holdings Inc. (CRWD) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRWD and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- CRWD is the larger of the two at $250.42B, about 271.9x SNCE ($921.1M).
- CRWD has hit the wire 17 times in the past 4 weeks while SNCE has been quiet.
- CRWD has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- CrowdStrike Holdings Inc.
- Science 37 Holdings Inc.
- Price
- $227.30-7.07%
- $5.75+0.17%
- Market cap
- $250.42B
- $921.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2020
- News (4w)
- 17
- 0
- Recent ratings
- 25
- 5
CrowdStrike Holdings Inc.
CrowdStrike Holdings, Inc. provides cloud-delivered solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. It offers 19 cloud modules on its Falcon platform through a software as a service subscription-based model that covers various security markets, such as corporate workload security, security and vulnerability management, managed security services, IT operations management, threat intelligence services, identity protection, and log management. The company primarily sells its platform and cloud modules through its direct sales team. CrowdStrike Holdings, Inc. was incorporated in 2011 and is headquartered in Sunnyvale, California.
Latest CRWD
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike Recommends Stockholders Reject the “Mini-Tender” Offer by Tutanota LLC
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike Named a Leader in the 2026 IDC MarketScape for Modern Endpoint Security for Enterprises
- SEC Form 4 filed by CrowdStrike Holdings Inc.
- CrowdStrike, AWS, and NVIDIA Expand Global Cybersecurity Startup Accelerator, Defining the Next Generation of Innovation for the Agentic Era
- Fal.Con Europe Sells Out at Record Pace as CrowdStrike Puts the AI Advantage in Defenders’ Hands
- SEC Form 4 filed by CrowdStrike Holdings Inc.
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance